詳細検索はこちら

永井 良三 ナガイ リョウゾウ

所属部署名学長
職名学長ホームページURL

プロフィール

研究キーワード

    心血管病学

研究分野

  • 内科系臨床医学 / 循環器内科学

所属学協会

  • 日本内科学会
  • 日本循環器学会
  • 日本高血圧学会
  • 日本心臓病学会
  • 日本動脈硬化学会
所属学協会を全て表示する
所属学協会閉じる
  • 日本内科学会
  • 日本循環器学会
  • 日本高血圧学会
  • 日本心臓病学会
  • 日本動脈硬化学会

委員歴

  • 2012年
    -
    2014年
    日本循環器学会 代表理事
  • 2012年
    -
    現在
    日本内科学会 評議員
  • 2014年
    -
    現在
    日本循環器学会 評議員
  • 2014年
    -
    現在
    日本動脈硬化学会 理事
  • 2014年
    -
    現在
    日本心不全学会 理事
審議会等委員を全て表示する
審議会等委員閉じる
  • 2012年
    -
    2014年
    日本循環器学会 代表理事
  • 2012年
    -
    現在
    日本内科学会 評議員
  • 2014年
    -
    現在
    日本循環器学会 評議員
  • 2014年
    -
    現在
    日本動脈硬化学会 理事
  • 2014年
    -
    現在
    日本心不全学会 理事

学位

  • 医学博士

研究活動

論文

  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
論文等(論文)を全て表示する
論文等(論文)閉じる
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年
  • Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
    Ueshima Kenji;Itoh Hiroshi;Kanazawa Nobuaki;Komuro Issei;Nagai Ryozo;Takeuchi Masahiro;Tsutomu Yamazaki;for the EMPATHY study group
    Journal of Atherosclerosis and Thrombosis 0(0) 2016年

MISC

  • Alendronate inhalation ameliorates elastase-induced pulmonary emphysema in mice by induction of apoptosis of apoptosis of
    永井 良三
  • Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nat Commun. 2014 epub
    永井 良三
  • Prognosis of myocardial infarction with left ventricular dysfunction in the coronary revascularization era.Subanalysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J. 2014;78(10):2483-91
    永井 良三
  • Association between serum IgG4 concentrations and the morphology of the aorta in patients who undergo cardiac computed tomography. J Cardiol. 2015;65(2):150-6
    永井 良三
  • ENPP2 contributes to adipose tissue expansion and insulin resistance in diet-induced obesity. Diabetes. 2014 Dec;63(12):4154-64
    永井 良三
  • The ω-3polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling. PLoS One. 2014 May 5;9(5):e96286.
    永井 良三
  • Periodontitis in cardiovascular disease patients with or without Marfan syndrome--a possible role of Prevotella intermedia. PLoS One. 2014 Apr 18;9(4):e95521.
    永井 良三
  • Cardioprotective function of cardiac macrophages. Cardiovasc Res. 2014 May 1;102(2):232-9.
    永井 良三
  • Fibroblast-mediated pathways in cardiac hypertrophy. J Mol Cell Cardiol. 2014 May;70:64-73.
    永井 良三
  • Association of serum IgG4 and soluble interleukin-2 receptor levels with epicardial adipose
    永井 良三
論文等(その他)を全て表示する
論文等(その他)閉じる
  • Alendronate inhalation ameliorates elastase-induced pulmonary emphysema in mice by induction of apoptosis of apoptosis of
    永井 良三
  • Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nat Commun. 2014 epub
    永井 良三
  • Prognosis of myocardial infarction with left ventricular dysfunction in the coronary revascularization era.Subanalysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J. 2014;78(10):2483-91
    永井 良三
  • Association between serum IgG4 concentrations and the morphology of the aorta in patients who undergo cardiac computed tomography. J Cardiol. 2015;65(2):150-6
    永井 良三
  • ENPP2 contributes to adipose tissue expansion and insulin resistance in diet-induced obesity. Diabetes. 2014 Dec;63(12):4154-64
    永井 良三
  • The ω-3polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling. PLoS One. 2014 May 5;9(5):e96286.
    永井 良三
  • Periodontitis in cardiovascular disease patients with or without Marfan syndrome--a possible role of Prevotella intermedia. PLoS One. 2014 Apr 18;9(4):e95521.
    永井 良三
  • Cardioprotective function of cardiac macrophages. Cardiovasc Res. 2014 May 1;102(2):232-9.
    永井 良三
  • Fibroblast-mediated pathways in cardiac hypertrophy. J Mol Cell Cardiol. 2014 May;70:64-73.
    永井 良三
  • Association of serum IgG4 and soluble interleukin-2 receptor levels with epicardial adipose
    永井 良三

書籍等出版物

  • The Biology of Kruppel-like Factor, editors Nagai R, Friedman SL, Kasuga M
    Springer 2009年 ISBN:978-4-431-87774-5
  • KLF5/BTEB2, a Krüppel-like Transcription Factor, Regulates Smooth Muscle Phenotypic Modulation.
    Signal Transduction and Cardiac Hypertrophy (Naranjan S. Dhalla, Larry Hryshko, Elissavet Kardami, Pawan K. Singal, KLUWER ACADEMIC PUBLISHERS) 2003年
著書を全て表示する
著書閉じる
  • The Biology of Kruppel-like Factor, editors Nagai R, Friedman SL, Kasuga M
    Springer 2009年 ISBN:978-4-431-87774-5
  • KLF5/BTEB2, a Krüppel-like Transcription Factor, Regulates Smooth Muscle Phenotypic Modulation.
    Signal Transduction and Cardiac Hypertrophy (Naranjan S. Dhalla, Larry Hryshko, Elissavet Kardami, Pawan K. Singal, KLUWER ACADEMIC PUBLISHERS) 2003年

受賞

  • 2012年08月 European Society of Cardiology (ESC) Gold Medal
  • 2010年03月 日本心血管内分泌代謝学会 高峰譲吉賞
  • 2009年05月 紫綬褒章
  • 2006年11月 日本医師会 医学賞
  • 1982年03月 日本心臓財団 佐藤賞
  • 1998年11月 第35回ベルツ賞 (2等賞)
  • 2002年07月 日本動脈硬化学会賞
受賞を全て表示する
受賞閉じる
  • 2012年08月 European Society of Cardiology (ESC) Gold Medal
  • 2010年03月 日本心血管内分泌代謝学会 高峰譲吉賞
  • 2009年05月 紫綬褒章
  • 2006年11月 日本医師会 医学賞
  • 1982年03月 日本心臓財団 佐藤賞
  • 1998年11月 第35回ベルツ賞 (2等賞)
  • 2002年07月 日本動脈硬化学会賞

外部的資金

  • 転写因子KLF5による心血管・代謝疾患の病態解明と治療法の開発
外部資金採択状況を全て表示する
外部資金採択状況閉じる
  • 転写因子KLF5による心血管・代謝疾患の病態解明と治療法の開発


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.